Publications by authors named "Falk Bechara"

Claim this Profile
D
Demographics, Comorbidity, Treatment, Healthcare Resource Utilization, and Costs Analysis of Hidradenitis Suppurativa in Dubai.
Anwar Al Hammadi, Samir Hantirah, Ashraf Mohamed Reda, Mohamed Farghaly, Falk Bechara

Dermatology· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Establishment of standardized definitions and a core set of outcome characteristics following hidradenitis suppurativa surgery developed by an expert Delphi consensus.
Linnea L Westerkam, Hessel H van der Zee, Falk G Bechara, Stephanie Goldberg, Gregor B Jemec

J Am Acad Dermatol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determinants of Satisfaction with Medical Care for Hidradenitis Suppurativa: Results from a Multicentre Survey in Germany.
Kerstin Wolk, Dagmar Wilsmann-Theis, Nessr Abu Rached, Giorgia Cugno, Rotraut Moessner, Falk G Bechara

Dermatol Ther (Heidelb)· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Hidradenitis Suppurativa Symptom and Impact Diary: Development and psychometric evaluation of a novel set of patient-reported outcomes for hidradenitis suppurativa.
John R Ingram, Magdalena B Wozniak, Anna Passera, Lorenz Uhlmann, Angela Llobet Martinez, Falk G Bechara

Br J Dermatol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Towards the development of upgrade criteria for the treatment of hidradenitis suppurativa with biologics.
Georgios Nikolakis, Erkan Alpsoy, Monika Arenbergerova, Falk G Bechara, Farida Benhadou

J Eur Acad Dermatol Venereol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bimekizumab demonstrated a favorable safety profile and high levels of efficacy with up to 2 years of treatment in patients with moderate to severe hidradenitis suppurativa: Pooled results from two phase 3 randomized, controlled trials and their open-label extension.
Christopher J Sayed, Brian Kirby, Amit Garg, Haley B Naik, Alexa B Kimball, Falk G Bechara

J Am Acad Dermatol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic burden of hidradenitis suppurativa based on healthcare resource utilization: German claims data analysis.
Falk G Bechara, Tanja Tran, Sandeep Kiri, Romy Bley, Kathrin Schlüter

J Dtsch Dermatol Ges· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Histological and clinical overlap of hidradenitis suppurativa and Crohn disease under IL-17 inhibition].
Lennart Ocker, Christina Scheel, Nessr Abu Rached, Martin Dörler, Markus Stücker, Falk Bechara

Dermatologie (Heidelb)· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[A practical approach for management of hidradenitis suppurativa in primary care].
Carolin Elisabeth Frost, Lennart Ocker, Falk Georges Bechara

MMW Fortschr Med· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hidradenitis Suppurativa: Higher Tobacco Pack-Years in Patients with Metabolic Comorbidities.
Yannik Haven, Nessr Abu Rached, Charlotte Michel, Daniel Myszkowski, Lennart Ocker, Falk G Bechara

Life (Basel)· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Towards a Paradigm Shift in Delivering Hidradenitis Suppurativa Care: a Narrative Review.
Falk G Bechara, Angelo V Marzano, Antonio Martorell, Hessel H van der Zee, Valeria Jordan M

Dermatol Ther (Heidelb)· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient involvement in treatment decisions is associated with increased therapy satisfaction in Hidradenitis suppurativa.
Giorgia Cugno, Sylke Schneider-Burrus, Georgios Kokolakis, Dagmar Wilsmann-Theis, Katharina Assaf, Falk G Bechara

Front Med (Lausanne)· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Body mass index is not associated with lymph node metastasis, infection, and seroma after sentinel lymph node biopsy in cutaneous melanoma.
Nessr Abu Rached, Fries Leifeld, Eggert Stockfleth, Daniel Myszkowski, Yannik Haven, Falk G Bechara

JAAD Int· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunohistochemical Characterisation of the Interstitial Inflammatory Environment: T-Cell- and B-Cell-Dominant Subtypes of Hidradenitis Suppurativa.
Nessr Abu Rached, Stefanie Bruckmüller, Martin Doerler, Hanna Telkemeyer, Lennart Ocker, Falk G Bechara

Dermatopathology (Basel)· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Haptoglobin Genotypes in Hidradenitis Suppurativa: Haptoglobin 2-2 Genotype Is Associated With Familial Hidradenitis Suppurativa and More Flares.
Nessr Abu Rached, Marina Skrygan, Lennart Ocker, Yannik Haven, Daniel Myszkowski, Falk G Bechara

Int J Dermatol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics of squamous cell carcinoma on hidradenitis suppurativa lesions - a case series.
Nessr Abu Rached, Riina Käpynen, Yannik Haven, Lennart Ocker, Carolin Frost, Falk G Bechara

J Dtsch Dermatol Ges· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical gender-driven patterns in hidradenitis suppurativa.
Nessr Abu Rached, Kristina Spies, Lennart Ocker, Daniel Myszkowski, Yannik Haven, Falk G Bechara

J Eur Acad Dermatol Venereol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low satisfaction with medical care among patients with hidradenitis suppurativa: A multicenter study.
Kerstin Wolk, Giorgia Cugno, Georgios Kokolakis, Sylke Schneider-Burrus, Dagmar Wilsmann-Theis, Falk G Bechara

J Eur Acad Dermatol Venereol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunohistochemical Expression of Haptoglobin in Skin Lesions of Hidradenitis Suppurativa.
Nessr Abu Rached, Hanna Telkemeyer, Marina Skrygan, Martin Doerler, Yannik Haven, Falk G Bechara

Life (Basel)· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Impact of Surgery on Quality of Life in Hidradenitis Suppurativa: Results from a Prospective Single-Center Study.
Lennart Ocker, Nessr Abu Rached, Anna Koller, Carolin Frost, Riina Käpynen, Falk G Bechara

Life (Basel)· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical differences between patients with and without a positive family history of hidradenitis suppurativa: a retrospective analysis of 1452 patients.
Nessr Abu Rached, Kristina Spies, Thilo Gambichler, Yannik Haven, Lennart Ocker, Falk Bechara

Br J Dermatol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and Validation of a Disease-specific Outcomes Tool for the Assessment of Patient Benefits of Treatment for Hidradenitis Suppurativa: the PBI-HS.
Natalia Kirsten, Matthias Augustin, Christine Blome, Janine Topp, Richard Schwager, Falk G Bechara

Acta Derm Venereol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endotyping Insulin-Glucose Homeostasis in Hidradenitis Suppurativa: The Impact of Diabetes Mellitus and Inflammation.
Nessr Abu Rached, Johannes W Dietrich, Lennart Ocker, Eggert Stockfleth, Yannik Haven, Falk G Bechara

J Clin Med· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementation Science to Improve the Diagnosis and Management of Hidradenitis Suppurativa: HELyx Study Design Overview.
John R Ingram, Georgios Kokolakis, Barry M McGrath, Marco Romanelli, Falk G Bechara

Dermatol Ther (Heidelb)· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HPV-16-Induced Squamous Cell Carcinoma in Hidradenitis Suppurativa: HPV Vaccination May Be Useful.
Nessr Abu Rached, Riina Käpynen, Martin Doerler, Lennart Ocker, Carolin Frost, Falk G Bechara

Cancers (Basel)· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis